BioAxone BioSciences, Inc.   Report issue

For profit Phase 3
Founded: Cambridge MA United States (2011)
Status: Left NME R&D (2021)

Organization Overview

First Clinical Trial
2011
NCT00610337
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now